Table 1.
Demographic Characteristics and Treatment History
| Patients (n=18) |
Controls (n=18) |
|
|---|---|---|
| Handedness (R/L) | 18/0 | 17/1 |
| Mean Education (SD) | 15.6 (3.8) | 15.9 (1.3) |
| Mean Est.VIQ | 109 (8.6) | 111 (8.1) |
| Age at study entry | ||
| Mean (SD) | 56.1 (8.2) | 56.2 (9.1) |
| Median (range) | 57 (39–69) | 59 (35–67) |
| Age at diagnosis | ||
| Mean (SD) | 55.3 (8.2) | N/A |
| Median (range) | 56.5 (38–68) | N/A |
| Diagnosis | ||
| Ovarian | 15 | N/A |
| Fallopian Tube | 2 | N/A |
| Peritoneal | 1 | N/A |
| Disease Stage | ||
| I | 1 | N/A |
| II | 0 | N/A |
| III | 13 | N/A |
| IV | 4 | N/A |
| Chemotherapy regimen | ||
| Paclitaxel, Carboplatin | 12 | N/A |
| Paclitaxel, Cisplatin | 4 | N/A |
| Paclitaxel, Cisplatin, Carboplatin | 2 | N/A |
| Mode of chemo administration | ||
| IV | 10 | N/A |
| IV/IP | 8 | N/A |
| Number of cycles completed | ||
| Mean (SD) | 6.3 (0.9) | N/A |
| Median (range) | 6 (4–8) | N/A |
| Time since chemo completion (days) | ||
| Mean (SD) | 81 (21) | N/A |
| Median (range) | 79.5 (28–119) | N/A |
| Menopausal at diagnosis (Y/N) | 11/7 | N/A |
| Menopausal at study entry (Y/N) | 18/0 | 13/5 |
SD= standard deviation; Est.VIQ= Estimated Verbal IQ (NAART (Blair and Spreen 1989), or Barona Index (Barona et al. 1984); IV= intravenous; IP=intraperitoneal